Search research articles
Contact Us
Filters
Showing results (571-580 of 623) with videos related to
Page
of 63
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 21, 2016
Reply to A. Indini et al
Troy Z Horvat, Nelly G Adel, Thu-Oanh Dang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 19, 2015
Immune-Related Adverse Events, Need for Systemic Immunosuppression, and Effects on Survival and Time to Treatment Failure in Patients With Melanoma Treated With Ipilimumab at Memorial Sloan Kettering Cancer Center
Troy Z Horvat, Nelly G Adel, Thu-Oanh Dang, et al.
Sarcoma
|
June 16, 2015
Phase II Trial of Gemcitabine and Docetaxel with Bevacizumab in Soft Tissue Sarcoma
Mark A Dickson, David R D'Adamo, Mary L Keohan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 10, 2013
Phase II trial of the CDK4 inhibitor PD0332991 in patients with advanced CDK4-amplified well-differentiated or dedifferentiated liposarcoma
Mark A Dickson, William D Tap, Mary Louise Keohan, et al.
The Oncologist
|
June 20, 2019
A Phase I Study of Binimetinib (MEK162) Combined with Pexidartinib (PLX3397) in Patients with Advanced Gastrointestinal Stromal Tumor
Evan Rosenbaum, Ciara Kelly, Sandra P D'Angelo, et al.
ESMO Open
|
March 21, 2026
Overall survival from the open-label phase II trial of palbociclib in patients with advanced well-differentiated/dedifferentiated liposarcoma
O O Babatunde, K Seier, G Schwartz, et al.
The Oncologist
|
August 22, 2018
A Phase II Trial of Sorafenib and Dacarbazine for Leiomyosarcoma, Synovial Sarcoma, and Malignant Peripheral Nerve Sheath Tumors
David R D'Adamo, Mark A Dickson, Mary L Keohan, et al.
Disease-A-Month : DM
|
September 22, 2023
Health equity in pediatrics: Current concepts for the care of children in the 21st century (Dis Mon)
Cheryl A Dickson, Berrin Ergun-Longmire, Donald E Greydanus, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 2024
Phase II Trial of <i>nab-</i>Sirolimus in Patients With Advanced Malignant Perivascular Epithelioid Cell Tumors (AMPECT): Long-Term Efficacy and Safety Update
Andrew J Wagner, Vinod Ravi, Richard F Riedel, et al.
Cancer Medicine
|
June 21, 2026
Concomitant Medication Effects on Immunotherapy Outcomes in Sarcoma: A Pooled Post Hoc Analysis of Seven Phase II Trials
Adel Shahnam, Kristen DiConza, Simran Jasnani, et al.
Page
of 63
Search research articles
Search
Showing results (571-580 of 623) with videos related to
Sort By:
Page
of 63
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 21, 2016
Reply to A. Indini et al
Troy Z Horvat, Nelly G Adel, Thu-Oanh Dang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 19, 2015
Immune-Related Adverse Events, Need for Systemic Immunosuppression, and Effects on Survival and Time to Treatment Failure in Patients With Melanoma Treated With Ipilimumab at Memorial Sloan Kettering Cancer Center
Troy Z Horvat, Nelly G Adel, Thu-Oanh Dang, et al.
Sarcoma
|
June 16, 2015
Phase II Trial of Gemcitabine and Docetaxel with Bevacizumab in Soft Tissue Sarcoma
Mark A Dickson, David R D'Adamo, Mary L Keohan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 10, 2013
Phase II trial of the CDK4 inhibitor PD0332991 in patients with advanced CDK4-amplified well-differentiated or dedifferentiated liposarcoma
Mark A Dickson, William D Tap, Mary Louise Keohan, et al.
The Oncologist
|
June 20, 2019
A Phase I Study of Binimetinib (MEK162) Combined with Pexidartinib (PLX3397) in Patients with Advanced Gastrointestinal Stromal Tumor
Evan Rosenbaum, Ciara Kelly, Sandra P D'Angelo, et al.
ESMO Open
|
March 21, 2026
Overall survival from the open-label phase II trial of palbociclib in patients with advanced well-differentiated/dedifferentiated liposarcoma
O O Babatunde, K Seier, G Schwartz, et al.
The Oncologist
|
August 22, 2018
A Phase II Trial of Sorafenib and Dacarbazine for Leiomyosarcoma, Synovial Sarcoma, and Malignant Peripheral Nerve Sheath Tumors
David R D'Adamo, Mark A Dickson, Mary L Keohan, et al.
Disease-A-Month : DM
|
September 22, 2023
Health equity in pediatrics: Current concepts for the care of children in the 21st century (Dis Mon)
Cheryl A Dickson, Berrin Ergun-Longmire, Donald E Greydanus, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 2024
Phase II Trial of <i>nab-</i>Sirolimus in Patients With Advanced Malignant Perivascular Epithelioid Cell Tumors (AMPECT): Long-Term Efficacy and Safety Update
Andrew J Wagner, Vinod Ravi, Richard F Riedel, et al.
Cancer Medicine
|
June 21, 2026
Concomitant Medication Effects on Immunotherapy Outcomes in Sarcoma: A Pooled Post Hoc Analysis of Seven Phase II Trials
Adel Shahnam, Kristen DiConza, Simran Jasnani, et al.
Page
of 63